Does Vitamin D Level Affect the Response to Antiviral Treatment in Egyptian Patients with Chronic Hepatitis C?
Journal Title: Viral Hepatitis Journal - Year 2017, Vol 23, Issue 2
Abstract
Objective: Vitamin D deficiency is common in patients with chronic liver disease. Several studies demonstrated that its levels are inversely related to the disease severity and documented improvement of the disease following supplementation especially regarding to hepatitis C virus (HCV) infection. To study level of vitamin D in Egyptian patients with chronic HCV infection and to investigate its correlation with activity and fibrosis scores of their liver biopsies, as well as the relationship of vitamin D levels with patients’ response to antiviral therapy. Materials and Methods: The study included 60 Egyptian patients with chronic HCV infection who were scheduled for antiviral medications (pegylated-interferon and ribavirin) for 48 weeks and 50 healthy age- and sex-matched individuals non-reactive for HCV antibodies as a control group. Serum 25-hydroxyvitamin D was measured in all patients and controls and compared with patients’ liver biopsy results and their virological response (after 48 weeks treatment) assessed by polymerase chain reaction for HCV. Results: Serum vitamin D levels were inversely correlated with activity and fibrosis scores in liver biopsy. On the other hand, 63.3% of cases had good response to interferon treatment and 36.7% of them had no response without significant difference in serum vitamin D levels between responders and non-responders (39.2±23.6 and 37.1±13.2 ng/mL, respectively). Conclusion: Vitamin D levels could affect liver necro-inflammatory process in Egyptian patients with chronic hepatitis C infection, but did not show significant effect on response to antiviral therapy.
Authors and Affiliations
Hoda Abdelbadie HUSSEIN, Hany Badreldin MOHAMAD, Mohamad Abdelhadi MASHAHEET, Maher Abubakr ALAMIR, Ghada Mohamad EZZAT
Keywords
Related Articles
- EP ID EP251833
- DOI 10.4274/vhd.73745
- Views 39
- Downloads 0
Real-life Outcomes of Tenofovir Disoproxil Fumarate Monotherapy in Nucleos(t)ide Analogue-naive and Nucleos(t)ide Analogue-experienced Chronic Hepatitis B Patients: A Single-center Experience
Objective: The aim of the study was to evaluate the long-term results of treatment efficacy and safety in nucleos(t)ide analogue-naive (NA-naive) and NA-experienced chronic hepatitis B (CHB) patients receiving tenofovir...
Direct-acting Antiviral Therapy for Mixed Genotype Chronic Hepatitis C Infection
Objectives: Literature data concerning the outcomes of direct acting antiviral (DAA) therapy in mixed genotype hepatitis C virus (HCV) infections are very limited, and the incidence of mixed HCV infection in Turkey is un...
The Epidemiology and Trend of Hepatitis C Infection in Hamadan Province: West of Iran, 2011-2016
Amaç: Hepatit C virüsü (HCV), küçük miktarda kanla temas yoluyla bulaşan bir virüstür. Bu çalışmada, 2011-2016 yılları arasında, Hamadan bölgesinde ardışık yedi yıl boyunca hepatit C enfeksiyonunun trendi ve epidemiyoloj...
Percutaneous Liver Needle Biopsy Methods Can Be Safe and Effective in Patients with Viral Hepatitis
Objectives: The aims of this study were to evaluate the biopsy methods used in terms of safety, and effectiveness as well as incidence, and severity of complications. Materials and Methods: This study was conducted as a...
A Rare Side Effect of Entecavir: Hepatomegaly and Steatosis
Hepatomegaly and steatosis are rare but potentially fatal side-effects of nucleoside analogues. Here, we present the case of development of hepatomegaly and steatosis in a 53-year-old male who had been treated with entec...